Stock Groups

Unilever offers 50 billion pounds for GSK unit -report -Breaking

© Reuters. FILEPHOTO: A general view of GlaxoSmithKline headquarters (GSK), Brentford, London. May 4, 2020. REUTERS/Matthew Childs

LONDON, (Reuters) – Unilever (NYSE) is attempting to acquire a pharmaceutical company. Glaxosmithkline The UK’s Sunday Times reports that the consumer goods industry of (LON) is valued at approximately 50 billion pounds ($68.4 million).

GSK Pfizer The newspaper reported that (NYSE:) which holds a minor stake in the division rejected the offer because it was too low.

($1 = 0.7314 pounds)

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.